4-(3-Methylbutanoyl)-N-[(pyridin-3-yl)methyl]-1H-pyrrole-2-carboxamide

Catalog No. :
ACZOMT004
CAS No. :
439111-98-5
Molecular Formula :
C16H19N3O2
Molecular Weight :
285.35

IUPAC Name:4-(3-methylbutanoyl)-N-(pyridin-3-ylmethyl)-1H-pyrrole-2-carboxamide

4-(3-Methylbutanoyl)-N-[(pyridin-3-yl)methyl]-1H-pyrrole-2-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$564.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(3-Methylbutanoyl)-N-[(pyridin-3-yl)methyl]-1H-pyrrole-2-carboxamide
IUPAC Name4-(3-methylbutanoyl)-N-(pyridin-3-ylmethyl)-1H-pyrrole-2-carboxamide
MDL No.MFCD03012625
Molecular FormulaC16H19N3O2
Molecular Weight285.35
SMILESO=C(C1=CC(C(CC(C)C)=O)=CN1)NCC2=CC=CN=C2
InChI KeyAMPXCCLKQGEKEK-UHFFFAOYSA-N
Synonym4-(3-METHYLBUTANOYL)-N-(3-PYRIDINYLMETHYL)-1H-PYRROLE-2-CARBOXAMIDE;4-(3-methylbutanoyl)-N-[(pyridin-3-yl)methyl]-1H-pyrrole-2-carboxamide;1H-Pyrrole-2-carboxamide, 4-(3-methyl-1-oxobutyl)-N-(3-pyridinylmethyl)-
CAS No.439111-98-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACZOMT004 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZOMT004 route product structure diagram
    ACZOMT004439111-98-5
Inquiry

2. ACZOMT004 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZOMT004 route product structure diagram
    ACZOMT004439111-98-5
Inquiry

Comments (0)